drugset / Trial / NCT00163761
Efficacy Study of Outpatient Therapy for Lymphoma
Non-randomizedCrossoverOpen-labelTreatment
Summary
This is a Phase II trial evaluating the efficacy (overall response rate) of a risk-adjusted outpatient based approach to lymphoma salvage therapy with vinorelbine, gemcitabine and pegfilgrastim and/or gemcitabine, ifosfamide, vinorelbine and pegfilgrastim.
Timeline
- Start
- 2002-12
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Filgastrim | Unknown | — | — |
| Comparator | Gemcitabine | Small molecule | — | — |
| Comparator | Ifosfamide | Small molecule | — | — |
| Comparator | Vinorelbine | Small molecule | — | — |